Status:
UNKNOWN
Azelaic Acid Versus Hydroquinone in Melasma
Lead Sponsor:
Callender Center for Clinical Research
Conditions:
Melanosis
Eligibility:
All Genders
18-89 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the safety and effectiveness of Azelaic Acid Gel to Hydroquinone Cream in the treatment of melasma.
Detailed Description
Melasma is a chronic condition in which dark areas appear on the forehead, cheeks, and upper lips. Hydroquinone is a skin lightener (or fade cream) and is one of the most commonly used medications for...
Eligibility Criteria
Inclusion
- must have stable moderate-severe epidermal or mixed melasma involving the face
- all races
- males and females
- persons taking birth control medication, hormone replacement therapy or any other hormone altering medication may participate only if they have not started or stopped the medication within the last 3 months
Exclusion
- if the person has only dermal melasma
- pregnancy, breastfeeding, a positive pregnancy test in the office or plans to become pregnant
- a known allergy or sensitivity ot azelaic acid or hydroquinone
- the use of photosensitizing medications (ex. tetracycline) within 3 months of the study.
- starting or stopping hormonal medication within 3 months
- chemical peels, microdermabrasion, or laser treatment within 6 months
- worsening or improving melasma
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00927771
Start Date
June 1 2009
End Date
December 1 2010
Last Update
June 25 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Callender Center for Clinical Research
Mitchellville, Maryland, United States, 20721